Editorials respond to PEPFAR reauthorization

NewsGuard 100/100 Score

President Bush on Wednesday signed into law legislation (HR 5501) that reauthorizes the President's Emergency Plan for AIDS Relief at $48 billion through 2013. Two newspapers have published editorials in response to the bill. Summaries appear below.

  • New York Times: Bush can be "justifiably proud of his administration's leadership in ramping up its commitments to the global efforts to control AIDS over the past five years and in proposing to do more in the next five." The "only hitch is whether the money will actually materialize in the form of appropriations," the editorial says, adding, "The signs in Congress are not good." The $48 billion called for in the PEPFAR reauthorization bill "implies appropriations of roughly $9 billion to $10 billion a year," the editorial says, adding, "But advocacy groups say the amounts emerging from Congressional appropriations committees for fiscal year 2009 will be little more than half of that." In addition, a report released this week by the Black AIDS Institute has "come up with a startling insight into the AIDS epidemic in this country by contrasting it with the global epidemic," according to the editorial. The Bush administration has not "shown the same zeal to control this domestic tragedy that it has shown in the global campaign," the editorial says, concluding, "Surely we should be doing as much to prevent the spread of the AIDS virus in our own communities as we are trying to do abroad" (New York Times, 8/1).
  • San Diego Union-Tribune: Bush "cemented his own legacy" by signing the bill, a Union-Tribune editorial says, adding that PEPFAR is "saving literally millions of lives, and it will stand as [Bush's] greatest bipartisan foreign policy achievement." With "less than six months remaining in the Bush presidency, the rest of his legacy remains, at best, cloudy," the editorial says, concluding, "But the impressive results of his battle against the scourge of AIDS cannot be denied. Its impact, in real lives saved, will be felt for many years to come" (San Diego Union-Tribune, 8/1).
In related news, the AP/Google.com on Thursday examined how the PEPFAR reauthorization bill "sets a goal of treating more than the two million patient target set in 2003, but how much more isn't clear." When signing the bill, Bush said, "With this funding, we will support treatment for at least three million people." However, the "bill itself doesn't set a specific target," according to the AP/Google.com. Early versions of the bill that passed the House included a specific target of treating at least three million people by 2013, but the target was removed in the final version. The bill now says that U.S. policy is to increase the number of people receiving treatment beyond the original goal of two million. According to the U.S. State Department, 1.7 million people received treatment as of March 31, and the original bill's target of reaching two million with treatment will be met by December (Euphrat, AP/Google.com, 7/31).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing